Robbins LLP Solicits Chemours Shareholders for Class Action Over Opteon Demand Claims
Oct 26, 2026
Robbins LLP is soliciting Chemours shareholders for a class action lawsuit alleging overstated Opteon demand caused unreliable 2026 guidance and a significant stock price decline.
Show all 13 updates